Published June 1, 2009 | Version v1
Journal article

Nuclear penetration of surface functionalized gold nanoparticles

  • 1. Department of Biology and Chemistry, City University of Hong Kong, Hong Kong (China)
  • 2. Department of Chemistry, University of Hong Kong, Hong Kong (China)

Description

Free gold nanoparticles easily aggregate when the environment conditions change. Here, gold nanoparticles (AuNPs) with average diameter of 3.7 nm were prepared and then modified with poly(ethylene glycol) (PEG) to improve stability. The gold nanoparticles were first surface-modified with 3-mercaptopropionic acid (MPA) to form a self-assembled monolayer and subsequently conjugated with NH2-PEG-NH2 through amidation between the amine end groups on PEG and the carboxylic acid groups on the particles. The biocompatibility and intracellular fate of PEG-modified gold nanoparticles (AuNP/MPA-PEG) were then studied in human cervical cancer (HeLa) cells. Cell viability test showed that AuNP/MPA-PEG did not induce obvious cytotoxicity. Both confocal laser scanning microscopy and transmission electron microscopy demonstrated that AuNP/MPA-PEG entered into mammalian cells and the cellular uptake of AuNP/MPA-PEG was time-dependent. Inductively coupled plasma mass spectrometry and confocal microscopy imaging further demonstrated that AuNP/MPA-PEG penetrated into the nucleus of mammalian cells upon exposure for 24 h. These results suggest that surface modification can enhance the stability and improve the biocompatibility. This study also indicates that AuNP/MPA-PEG can be used as potential nuclear targeted drug delivery carrier.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.taap.2009.03.009

Additional details

Identifiers

DOI
10.1016/j.taap.2009.03.009;
PII
S0041-008X(09)00120-3;

Publishing Information

Journal Title
Toxicology and Applied Pharmacology
Journal Volume
237
Journal Issue
2
Journal Page Range
p. 196-204
ISSN
0041-008X
CODEN
TXAPA9

Optional Information

Copyright
Copyright (c) 2009 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.